Literature DB >> 8936912

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

T J Spencer1, J Biederman, M Harding, D O'Donnell, S V Faraone, T E Wilens.   

Abstract

OBJECTIVE: To reevaluate the hypothesis that stimulants cause growth deficits in children with attention-deficit hyperactivity disorder (ADHD).
METHOD: Growth deficits in height and weight were examined in 124 children and adolescents with ADHD and 109 controls, using appropriate correction by age and parental height measures and attending to issues of pubertal stage, treatment, and psychiatric comorbidity.
RESULTS: Small but significant differences in height were identified between ADHD children and controls. However, height deficits were evident in early but not late adolescent ADHD children and were unrelated to use of psychotropic medications. There was no evidence of weight deficits in ADHD children relative to controls, and no relationship between measures of malnutrition and short stature was identified.
CONCLUSIONS: ADHD may be associated with temporary deficits in growth in height through mid-adolescence that may normalize by late adolescence. This effect appears to be mediated by ADHD and not its treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8936912     DOI: 10.1097/00004583-199611000-00014

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  36 in total

1.  Dexmethylphenidate extended release: in attention-deficit hyperactivity disorder.

Authors:  Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Authors:  Benedetto Vitiello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

3.  Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.

Authors:  Jonathan R Stevens; Timothy E Wilens; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-28

4.  Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.

Authors:  Laurence L Greenhill; James M Swanson; Lily Hechtman; James Waxmonsky; L Eugene Arnold; Brooke S G Molina; Stephen P Hinshaw; Peter S Jensen; Howard B Abikoff; Timothy Wigal; Annamarie Stehli; Andrea Howard; Michael Hermanussen; Tomasz Hanć
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-15       Impact factor: 8.829

5.  Attention deficit disorder, stimulant use, and childhood body mass index trajectory.

Authors:  Brian S Schwartz; Lisa Bailey-Davis; Karen Bandeen-Roche; Jonathan Pollak; Annemarie G Hirsch; Claudia Nau; Ann Y Liu; Thomas A Glass
Journal:  Pediatrics       Date:  2014-03-17       Impact factor: 7.124

Review 6.  Growth on stimulant medication; clarifying the confusion: a review.

Authors:  A Poulton
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

7.  ADHD, stimulant treatment, and growth: a longitudinal study.

Authors:  Elizabeth B Harstad; Amy L Weaver; Slavica K Katusic; Robert C Colligan; Seema Kumar; Eugenia Chan; Robert G Voigt; William J Barbaresi
Journal:  Pediatrics       Date:  2014-09-01       Impact factor: 7.124

Review 8.  Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.

Authors:  M Cyr; C S Brown
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

9.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 10.  Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.

Authors:  Lily Hechtman; Brian Greenfield
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.